Drug safety between pharmacovigilance and traceability
Recent events regarding the vaccine currently used against the Covid-19 infection has highlighted the importance of the monitoring activities of adverse reactions and of the drug...
Recent events regarding the vaccine currently used against the Covid-19 infection has highlighted the importance of the monitoring activities of adverse reactions and of the drug...
Italian consumers pay more and more attention to the information reported in labels and to the quality of the products they are...
On 11 March 2021 Di Renzo Regulatory Affairs attended a digital event on clinical trials with medical devices, and the impact...
The world of food supplements is under continuous development and growth. More and more Italian and foreign companies are opting...
The onset of unexpected adverse reaction and the measures to be taken to protect patients’ health have been very much debated lately....
All manufacturing activities provide for the attribution of a lot number for each batch of manufactured goods; this is even more...
Last 15 October, the Italian Medicine Agency had announced the introduction of a new simplified price and reimbursement procedure for...
The presence of products made in China and marketed in Europe and in Italy is often talked about. Several types of product...
In a world that is more and more globalised, managing international issues was made easier by legal and procedural harmonisation in every...
Some product groups can put manufacturers in a difficult position, as they are not always able to place their product...
Headquarter
Legal Office
Sede di Milano
© 2021 Di Renzo® s.r.l.
Sede legale: Viale Manzoni 59 – 00185 Roma
Sede operativa: Via dell’Arco di Travertino 11 – 00178 Roma
+39 0677209020 - P. Iva 07227271009 - Cookies Policy - Trattamento dei dati
© Copyright 2025 Di Renzo Regulatory Affairs. All Rights Reserved by Di Renzo Regulatory Affairs